Baker / Tisch Capital (GP), LLC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker / Tisch Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker / Tisch Capital (GP), LLC. Baker / Tisch Capital (GP), LLC is a Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and a 10% Owner in ADOLOR CORP ($ADLR) and a Director in SEATTLE GENETICS INC /WA ($SGEN) and a 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Address: 667 MADISON AVENUE 21ST FLOOR NEW YORK US 10065 NY
Companies in which Baker / Tisch Capital (GP), LLC is an Insider
ADOLOR CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker / Tisch Capital (GP), LLC: 10% Owner
Holdings: 0 shares
Latest Transaction: Jan 03 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AUXILIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker / Tisch Capital (GP), LLC: 10% Owner
Holdings: 67,322 shares
Latest Transaction: Aug 03 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker / Tisch Capital (GP), LLC: Director
Holdings: 450,461 shares
Current Value: $27,383,524
Latest Transaction: Jan 04 2012
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNAGEVA BIOPHARMA CORP
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker / Tisch Capital (GP), LLC: Director
Holdings: 206,800 shares
Latest Transaction: Nov 04 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Baker / Tisch Capital (GP), LLC
Sentiment: All, ADLR, AUXL, SGEN, GEVA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2012 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | X | 6.25 | 49,563 | 309,769 | 0 | |
| Jan 04 2012 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | X | 6.25 | 49,563 | 309,769 | 450,461 | 400.9 K to 450.5 K (+12.36 %) |
| Jan 03 2012 | ADLR | ADOLOR CORP | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | U | 4.25 | 12,679 | 53,886 | 0 | 12.7 K to 0 (-100.00 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker / Tisch Capital (GP), LL ... | Director | Grant | A | 0.00 | 55,187 | 0 | 206,800 | 151.6 K to 206.8 K (+36.40 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker / Tisch Capital (GP), LL ... | Director | Grant | A | 0.00 | 53,754 | 0 | 151,613 | 97.9 K to 151.6 K (+54.93 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker / Tisch Capital (GP), LL ... | Director | Grant | A | 0.00 | 56,954 | 0 | 97,859 | 40.9 K to 97.9 K (+139.23 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker / Tisch Capital (GP), LL ... | Director | Grant | A | 0.00 | 8,821 | 0 | 40,905 | 32.1 K to 40.9 K (+27.49 %) |
View all Baker / Tisch Capital (GP), LLC insider transactions.